APA (7th ed.) Citation

JN, G., CEP, S., AO, S., DZ, Q., TM, B., E, L., . . . HH, C. (2026). A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. The oncologist, 31(6), . https://doi.org/10.1093/oncolo/oyag180

Chicago Style (17th ed.) Citation

JN, Graff, et al. "A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer." The Oncologist 31, no. 6 (2026). https://doi.org/10.1093/oncolo/oyag180.

MLA (9th ed.) Citation

JN, Graff, et al. "A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer." The Oncologist, vol. 31, no. 6, 2026, https://doi.org/10.1093/oncolo/oyag180.